Dashboard
Manage Tickers

SNSESensei Biotherapeutics, Inc.

Nasdaq senseibio.com


$ 0.96 $ 0.01 (0.85 %)    

Wednesday, 24-Apr-2024 13:40:20 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 430.17 $ -2.06 (-0.48 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ -1.92 (-0.38 %)
TLT $ 87.78 $ -0.62 (-0.7 %)
GLD $ 215.92 $ 1.28 (0.6 %)
$ 1.0001
$ 0.96
$ 0.00 x 0
$ 0.00 x 0
$ 0.96 - $ 0.96
$ 0.51 - $ 1.72
44,885
na
27.96M
$ 1.23
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-29-2024 12-31-2023 10-K
2 11-07-2023 09-30-2023 10-Q
3 08-03-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-29-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-15-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-30-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

sensei-biotherapeutics-to-present-topline-clinical-data-from-the-sns-101-phase-i-dose-escalation-study-at-the-2024-asco-annual-meeting
Sensei Biotherapeutics To Present Topline ...
04/24/2024 20:52:35

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development o...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
04/22/2024 20:31:12

sensei-biotherapeutics-announces-nature-communications-publication-describing-mechanism-of-action-of-sns-101-selectively-targeting-the-active-form-of-vista-within-the-tumor-microenvironment
Sensei Biotherapeutics Announces Nature Co...
04/04/2024 20:10:49

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development o...

sensei-biotherapeutics-cfo-to-resign-all-positions-with-co-effective-april-10
Sensei Biotherapeutics CFO To Resign All P...
04/02/2024 11:48:59

-SEC Filing

sensei-biotherapeutics-fy-eps-122-up-from-158-yoy-2023-year-end-cash-cash-equivalents-and-marketable-securities-of-658m-is-expected-to-provide-cash-runway-into-fourth-quarter-of-2025
Sensei Biotherapeutics FY EPS $(1.22) Up F...
02/28/2024 12:36:08

Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(1.22) per share. This is a 22.78 percent increase over loss...

sensei-biotherapeutics-says-it-completed-sns-101-monotherapy-dose-escalation-through-15-mgkg-with-no-dose-limiting-toxicities-highlights-strong-balance-sheet-with-cash-runway-extended-into-q4-of-2025
Sensei Biotherapeutics Says It Completed S...
01/04/2024 12:43:25

hc-wainwright--co-initiates-coverage-on-sensei-biotherapeutics-with-buy-rating-announces-price-target-of-4
HC Wainwright & Co. Initiates Coverage On ...
12/04/2023 11:41:46

HC Wainwright & Co. analyst Edward White initiates coverage on Sensei Biotherapeutics (NASDAQ:SNSE) with a Buy rating an...

sensei-biotherapeutics-q3-eps-028-beats-034-estimate-cash-cash-equivalents-and-marketable-securities-of-72m-expected-to-fund-operations-into-the-second-half-of-2025
Sensei Biotherapeutics Q3 EPS $(0.28) Beat...
11/07/2023 12:42:03

Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate o...

why-best-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket
Why BEST Shares Are Trading Higher By Arou...
11/06/2023 13:08:25

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 1...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/06/2023 13:06:45

on-november-6-2023-sensei-biotherapeutics-confirmed-that-on-october-25-2023-it-received-an-unsolicited-proposal-from-newtyn-management-to-acquire-the-company-at-100-per-share-in-cash
On November 6, 2023, Sensei Biotherapeutic...
11/06/2023 11:16:15

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
11/03/2023 21:31:26

sensei-biotherapeutics-reports-clinical-data-for-sns-101-at-2023-sitc-annual-meeting
Sensei Biotherapeutics Reports Clinical Da...
11/03/2023 20:06:24

- Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacok...

sensei-biotherapeutics-to-present-initial-clinical-data-from-dose-escalation-trial-of-sns-101-at-2023-sitc-annual-meeting
Sensei Biotherapeutics To Present Initial ...
10/25/2023 13:11:19

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development o...

sensei-biotherapeutics-presents-trial-in-progress-poster-for-phase-12-clinical-study-of-sns-101-at-esmo-2023
Sensei Biotherapeutics Presents Trial-in-P...
10/23/2023 11:36:09

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
10/05/2023 17:22:02

  On Thursday, 369 companies hit new 52-week lows.

stocks-that-hit-52-week-lows-on-tuesday
Stocks That Hit 52-Week Lows On Tuesday
10/03/2023 18:37:58

  On Tuesday, 647 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
09/29/2023 18:09:27

  Friday's session saw 112 companies set new 52-week lows.

sensei-biotherapeutics-announces-initiation-of-combination-arm-for-phase-12-clinical-study-of-sns-101-with-regenerons-libtayo
Sensei Biotherapeutics Announces Initiatio...
09/27/2023 11:32:17

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development o...

sensei-biotherapeutics-presents-new-preclinical-data-reinforcing-sns-101-pharmacokinetic-profile-safety-characteristics-and-mechanism-of-action-at-the-seventh-cri-enci-aacr-international-cancer-immunotherapy-conference
Sensei Biotherapeutics Presents New Precli...
09/21/2023 11:30:55

- New data from multi-dose GLP toxicology study of SNS-101 in cynomolgus monkeys further support exceptional PK and safety prof...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION